DossierENTITY

recurring heart events

Coverage of recurring heart events in the Nexus archive.

Earliest in view: Jul 9 · 11:20 UTCMost recent: Jul 9 · 11:20 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 9 · 11:20 UTCQUARTZ
AstraZeneca stock plunges after late-stage heart drug trial misses its target
AstraZeneca's stock fell sharply after its late-stage heart drug trial for Wainua failed to reduce cardiovascular deaths and recurring heart events, causing a $27 billion drop in market value.